CONTACT DERMATITIS, published by WILEY, is a leading international journal focused on the vital field of dermatology, particularly examining the diagnosis, treatment, and management of contact dermatitis and related skin conditions. With origins dating back to 1975 and a planned convergence period extending to 2024, this esteemed journal serves as a crucial resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge in dermatological practices. In the latest rankings, it has achieved a commendable Q2 classification in Dermatology and Q3 classification in Immunology and Allergy for 2023, underscoring its significance within these dynamic fields. Moreover, it holds a notable ranking of #29/142 in Medicine & Dermatology and #130/233 in Medicine & Immunology and Allergy according to Scopus metrics, placing it in the top tier of scholarly publications. While the journal operates on a subscription basis, its comprehensive reviews, original articles, and insightful research findings are invaluable for pushing the boundaries of current dermatological and immunological knowledge. By fostering a deeper understanding of the complexities of skin reactions and their implications, CONTACT DERMATITIS plays a vital role in connecting research with clinical practice, making it an essential read for anyone engaged in the field.

The Journal of Cataract and Refractive Surgery, published by Lippincott Williams & Wilkins, stands as a cornerstone in the field of ophthalmology, documenting groundbreaking research and advancements in cataract and refractive surgical techniques since its inception in 1986. With an impressive Q1 ranking across key categories such as Ophthalmology, Sensory Systems, and Surgery, this journal plays a vital role in disseminating high-impact findings that shape clinical practices and enhance patient outcomes. Its rigorous peer-review process ensures the publication of only the most relevant and innovative studies, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing the field of eye care. Although not an open-access publication, the journal's commitment to excellence is reflected in its robust citation metrics and significant standing in various Scopus rankings; it ranks 63rd in Surgery and 23rd in Ophthalmology, underscoring its influence and prestige in the medical community. For those invested in the evolving landscape of eye surgery, the Journal of Cataract and Refractive Surgery remains a pivotal source of knowledge and forward-thinking perspectives.

Ocular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.

BMJ Open Ophthalmology is an esteemed, open-access journal dedicated to the field of ophthalmology, published by the renowned BMJ Publishing Group. Established in 2016, this journal has quickly made its mark within the ophthalmology community, achieving a respectable Q2 ranking in the 2023 category quartiles. It is indexed in Scopus, boasting a commendable ranking of **#52** out of **137** in the medicine discipline of ophthalmology, placing it in the **62nd percentile**. This global platform is committed to disseminating high-quality research, clinical studies, and innovative practices that propel the understanding and treatment of eye diseases. With its open access model, BMJ Open Ophthalmology ensures that vital research is readily available to health professionals, researchers, and students, fostering collaboration and advancing knowledge within the field. The journal is based in London, United Kingdom, and continues to welcome submissions that explore the latest advancements in ophthalmic science, contributing to enhanced patient care and outcomes.

OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.

Clinical and Experimental Optometry, published by Taylor & Francis Ltd, is a distinguished journal dedicated to advancing the field of optometry and ophthalmology. With an impressive scope covering both clinical practices and experimental research, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. Recognized in the Q2 category for Ophthalmology and Q1 category for Optometry in 2023, it underscores its significance in fostering innovative research and clinical knowledge. The journal has been in publication since 1986 and continues to accept contributions up until 2024, reflecting its ongoing commitment to disseminating high-quality scholarly work. With a Scopus ranking of 40 in Ophthalmology and 5 in Health Professions - Optometry, it is positioned among the leading journals in the field. Although not an open-access journal, it remains integral for anyone invested in the latest trends and findings in vision science, making it an essential part of the academic landscape in the UK and beyond.

Clinical Ophthalmology is a leading Open Access journal published by Dove Medical Press Ltd, dedicated to advancing the field of ophthalmology through peer-reviewed research and clinical studies. With a strong impact factor and ranked in the Q1 category of ophthalmology as of 2023, this journal is recognized for its significant contribution to the body of knowledge pertaining to eye health, vision science, and clinical practice. Its Scopus ranking places it within the top 30% of journals in the field, reflecting its influence and relevance in both academic and clinical landscapes. Since its inception in 2007, Clinical Ophthalmology has established a reputation for fostering high-quality research, providing a platform for researchers, professionals, and students to share their findings and insights. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, supporting innovation and collaboration in the pursuit of better patient outcomes worldwide. For those engaged in ophthalmological research and clinical practice, Clinical Ophthalmology serves as an invaluable resource and a hub for the latest developments in the field.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

CORNEA is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the rapidly advancing field of ophthalmology with a particular emphasis on corneal research and diseases. With an impact factor categorized in the prestigious Q1 quartile for its discipline, CORNEA has established itself as a leading platform for the dissemination of both fundamental and clinical studies since its inception in 1982. The journal is ranked 25th out of 137 in the Scopus Medicine-Ophthalmology category, placing it in the 82nd percentile among its peers, which underscores its vital role in influencing ocular research and clinical practices. While the journal is not currently open access, it provides valuable insights and updates for professionals, researchers, and students working to advance knowledge in corneal health, contributing significantly to the ongoing dialogue in the ophthalmological community. With a commitment to excellence, CORNEA continues to publish high-quality research and reviews in its pursuit to improve ocular outcomes and patient care.

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.